Implementing an Enhanced Standardized Medication Therapy Management Approach Within a Primary Care Setting
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Qualitative description of process-related challenges and successes as assessed by observation and survey
研究概览
简要总结
The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.
详细描述
The specific aim of this study is to implement a Medication Therapy Management (MTM) service in primary care that is enhanced by the incorporation of pharmacogenomics (PGx) and medication risk mitigation (MRM) factor technology and is standardized by a systematic approach to evidence- and personalized-based medicine. The primary objective is to implement the systematic approach to delivering an enhanced MTM service in a primary care setting. Secondary objectives include: determine how successful the communication between prescriber and pharmacist is within implementing the service, determine how PGx testing can be incorporated into primary care prescribers' daily work flow, determine if patients are receptive to PGx testing, determine how satisfied prescribers are with an enhanced MTM clinical service and their confidence to conduct on their own, and determine if enhanced MTM optimizes or changes drug therapy for patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Receiving primary health care from Elmwood Family Physicians; and
- •Medicare beneficiary; and
- •Currently prescribed at least 7 medications, or prescriber feels patient would benefit from enhanced medication therapy management, or actual or suspected medication-related problem
排除标准
- •Not willing to participate in the study and sign informed consent; or
- •Non-English speaking or designated surrogate as translator not available
结局指标
主要结局
Qualitative description of process-related challenges and successes as assessed by observation and survey
时间窗: 3 months
Implementation
次要结局
- Quantitative description of bidirectional communication as assessed by turn-around times from pharmacist's recommendations delivered to prescriber's responses received(3 months)
- Qualitative description of incorporation of pharmacogenomic testing into workflow and receptiveness as assessed by observation and survey(3 months)
- Qualitative description of prescriber satisfaction with enhanced medication therapy management services as assessed by survey(3 months)
- Qualitative and quantitative description of potential impact of enhanced medication therapy management services on drug regimens as assessed by before-and-after observations(3 months)